How a new antibiotic made by China is helping the world beat tuberculosis
An antibiotic made from the bacillus that causes tuberculosis could help the world fight the deadly disease, according to a study by researchers from China’s Jiangsu Provincial Health Administration.
According to the study, the antibiotic, called beyBlade, could also reduce antibiotic resistance among bacteria that causes other respiratory illnesses, including pneumonia and coronavirus.
“We’ve been using this antibiotic in China for the last 30 years, but it’s not always effective,” said Dr. Jianwen Zhang, a research fellow at the university of Shanghai and lead author of the study.
“So we thought, ‘How can we make a new, more effective, and cost-effective antibiotic?'”
Zhang and his team created a new strain of the bacteroides, a common type of bacteria that grows in the intestines of cattle and people, and they found that the new antibiotic could be used as an effective anti-tuberculosis drug.
“We can make a batch of it that’s as effective as the one we have now,” Zhang said.
“The compound we developed is much more potent and safe than the ones we have already made,” Zhang told CNN.
“It has a very low toxicity,” he added.
“When it gets into the bloodstream, it’s able to kill many of the bacteria that cause tuberculosis, including the ones that cause pneumonia, and it also stops the infection in its tracks.”
The research team is currently testing the compound in pigs, but Zhang said they’re hopeful that the compound will be ready to be administered in humans in the next six months.””
The drug can even be used in people.”
The research team is currently testing the compound in pigs, but Zhang said they’re hopeful that the compound will be ready to be administered in humans in the next six months.
“I’m very optimistic about this,” Zhang added.
The researchers are working to develop the compound and test it in humans as soon as possible.
The study was published in the journal Nature Biotechnology.